It would be of interest in the future to determine if overexpression or silencing of CYP1B1 affects eicosanoid levels in prostate cancer tissue and how individual eicosanoids affect caspase-1 expression and activity in vitro and in vivo. This evidence concerns the gene CYP1B1 and Familial prostate cancer.